The use of sodium valproate as an antiseizure medication (ASM) in pregnancy can increase the risk of fetal malformations; however, the teratogenic effects of other ASMs remain unclear. In a recent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results